Aveanna Healthcare Holdings Inc. (AVAH) Q4 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call indicates strong cash collections and cost efficiency, contributing to a positive free cash flow. The Family First acquisition is expected to be accretive and minimally impact leverage. Positive growth outlooks across business segments and AI initiatives further enhance sentiment. While some uncertainties exist, such as California's home-based nursing rates, the overall sentiment is positive due to strong financial performance and strategic growth plans.
Key Financial Performance
Revenue for Q4 2025 $662 million, representing a 27.4% increase over the prior year period. The increase was primarily due to improved rate and volume environment and continued cost savings initiatives.
Adjusted EBITDA for Q4 2025 $85 million, representing a 54% increase over the prior year period. This growth was driven by improved rate and volume environment and cost savings initiatives.
Revenue for full year 2025 $2.433 billion, representing a 20.2% increase over the prior year period. The increase was attributed to improved rate and volume environment and cost savings initiatives.
Adjusted EBITDA for full year 2025 $320.8 million, representing a 74.8% increase over the prior year period. This was due to improved rate and volume environment and cost savings initiatives.
Private Duty Services Revenue for Q4 2025 $541 million, a 28.1% increase over the prior year. This was driven by approximately 12.4 million hours of care, a volume increase of 17.9%, and a revenue per hour increase of 10.2%.
Home Health & Hospice Revenue for Q4 2025 $69.3 million, a 27.3% increase over the prior year. This was driven by 10,400 total admissions (22.4% growth) and 14,000 total episodes of care (25% growth).
Medical Solutions Revenue for Q4 2025 $52.5 million, a 21.3% increase over the prior year. This was driven by approximately 92,000 unique patients served and a revenue per unique patient served increase of 17.9%.
Consolidated Gross Margin for Q4 2025 $213.3 million or 32.2%. This reflects improved rate environment, increased volumes, and enhanced operational efficiencies.
Cash Generated by Operating Activities for 2025 $125.9 million. This was driven by strong cash collections and cost efficiency efforts.
Free Cash Flow for 2025 $131 million. This was driven by strong cash collections and cost efficiency efforts.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Family First Homecare acquisition: Aveanna announced the acquisition of Family First Homecare, a Florida-based company specializing in in-home pediatric care. The transaction is expected to close in Q2 2026, pending regulatory approvals.
Revenue Growth: Aveanna reported a 27.4% increase in Q4 2025 revenue to $662 million and a 20.2% increase in full-year 2025 revenue to $2.433 billion. Growth was driven by improved rates, volume environment, and cost-saving initiatives.
Preferred Payer Agreements: The company added 8 new preferred payer agreements in 2025, achieving a total of 30 agreements. The goal for 2026 is to add 8 more agreements, targeting 38 by year-end.
Operational Efficiencies: Aveanna achieved a 54% increase in Q4 adjusted EBITDA to $85 million and a 74.8% increase in full-year adjusted EBITDA to $320.8 million. This was attributed to improved rates, volume growth, and cost-saving measures.
Caregiver Hiring and Retention: The company improved caregiver hiring and retention trends by aligning efforts with payers offering enhanced reimbursement rates and value-based agreements.
Strategic Initiatives for 2026: Aveanna outlined five strategic initiatives for 2026: strengthening partnerships with government and preferred payers, improving clinical outcomes, implementing AI and automation for efficiency, pursuing acquisitions, and engaging employees.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Labor Market Challenges: The labor environment remains a primary challenge for Aveanna, impacting the company's ability to resume its growth trajectory. Despite improvements in caregiver hiring and retention trends, the labor market continues to be a challenging factor.
Regulatory and Legislative Risks: The company relies heavily on legislative efforts to improve reimbursement rates and Medicaid rate integrity. Any failure to achieve these legislative goals or changes in government policies could adversely impact financial performance.
Preferred Payer Strategy Execution: The company's growth strategy is heavily dependent on increasing preferred payer agreements. Failure to secure these agreements or align caregiver capacity with preferred payers could hinder revenue and margin growth.
Economic and Rate Environment: The company’s financial performance is sensitive to reimbursement rate enhancements and economic conditions. Any unfavorable changes in these areas could negatively impact revenue and profitability.
Acquisition Integration Risks: The integration of acquisitions like Family First Homecare poses risks, including potential delays, higher-than-expected costs, or failure to realize anticipated synergies.
Debt and Interest Rate Exposure: Aveanna has significant variable rate debt, which, despite being hedged, exposes the company to interest rate risks. Any adverse changes in interest rates could impact financial stability.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Preferred Payer Agreements: The company plans to increase the number of Private Duty Services preferred pay agreements from 30 to 38 by the end of 2026. Additionally, in Home Health, the company aims to grow preferred pay agreements from 45 to over 50 by the end of 2026. In Medical Solutions, the target is to grow preferred pay agreements from 18 to 25 by the end of 2026.
Legislative Goals for Reimbursement Rates: The company expects to achieve high single-digit state rate enhancements for 2026, focusing on cost-of-living adjustments and wage increases.
Acquisition Strategy: The company plans to grow through acquisitions, including the recently announced Family First Homecare acquisition, expected to close in Q2 2026.
Artificial Intelligence and Automation: The company plans to implement high-priority AI and automation efforts to improve operational efficiency and productivity gains.
Revenue and Adjusted EBITDA Projections for 2026: The company anticipates 2026 revenue in the range of $2.54 billion to $2.56 billion and adjusted EBITDA in the range of $318 million to $322 million. This guidance excludes the impact of the Family First acquisition.
Private Duty Services Growth: The company expects preferred payer volumes to grow to the low 60% range in 2026, with continued alignment of caregiver capacity and recruitment efforts.
Home Health & Hospice Growth: The company projects episodic payer mix to remain above 75% with organic growth rates approaching double digits in 2026.
Medical Solutions Growth: The company expects mid-single-digit revenue growth in the first few quarters of 2026, returning to double-digit growth by the end of the year.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:What is the impact of the Family First acquisition on leverage and margin contribution?
A:The Family First acquisition is valued at about 7.5x post-synergy EBITDA. It will have a minimal short-term impact on leverage, and the company expects to deleverage slightly in 2026. The acquisition is expected to be accretive over time.
Q:What is the geographic coverage of preferred provider arrangements and plans for expansion?
A:The company has densified its current geographies, including new Medicaid states like New Mexico and Kansas. Major payers in major markets have been landed, but there are plans to expand into states like Ohio, West Virginia, Kentucky, and Tennessee in the back half of 2026 and 2027.
Q:What are the revenue and EBITDA contributions expected from the Family First acquisition?
A:The Family First acquisition is expected to contribute approximately $120 million in revenue. The EBITDA contribution is based on a 7.5x multiple of the purchase price, with the exact impact depending on the timing of the closing.
Q:What is the bridge for 2026 EBITDA guidance?
A:The 2026 EBITDA guidance starts at $300 million, adjusted for retro rate increases, cash collections, and the 53rd week in 2025. Organic growth is expected to bring it to $320 million, with a 7% implied EBITDA growth.
Q:What is the episodic mix in the Home Health & Hospice segment and its growth outlook?
A:The episodic mix is trending above 75% and could reach 80%. The segment has achieved 25% organic year-over-year admission and episodic growth, with plans to continue growing through both organic and inorganic means.
Q:What is the outlook for the Medical Solutions business in 2026?
A:The Medical Solutions business expects to normalize gross margins to 43%-45% in Q1 2026. Preferred payer numbers are expected to grow significantly, with double-digit organic growth anticipated in the latter half of 2026.
Q:What is the impact of wage pass-throughs on PDS gross margins?
A:PDS gross margins are expected to stabilize at 27%-28%, with continued wage pass-throughs to caregivers aligned with reimbursement rate increases.
Q:What is the outlook for California's home-based nursing rates?
A:There is no PDN rate increase in California's 2026-2027 budget. The company is lobbying for inclusion in the May revised budget but considers the likelihood low. California's materiality to the company has decreased over time.
Q:How are weather-related impacts and respiratory seasonality factored into the 2026 outlook?
A:Weather-related impacts and respiratory seasonality have been managed without significant changes to guidance. The company has a no-excuse mentality and expects no material impact.
Q:What is the impact of fuel prices on caregiver travel costs?
A:80% of revenues are from shift care in the home, which does not involve travel reimbursement. Home Health & Hospice, representing 12% of revenue, is the most impacted segment, but the overall impact is minimal.
Q:What is the timeline for value-based arrangements with preferred payers?
A:Value-based arrangements typically take 6-18 months to implement after signing a preferred payer. The company expects to increase value-based agreements from 10 to 14-15 in 2026.
Q:What is the volume growth outlook for the Private Duty Services (PDS) segment?
A:PDS is expected to return to a normalized growth rate of 5%-7%, with 3.5%-4% volume growth and 1%-1.5% rate growth.
Q:What are the company's AI and automation initiatives?
A:The company has focused on back-office automation for revenue cycle management and is piloting AI initiatives for caregiver engagement and scheduling. These efforts are expected to impact cost structure and margins over time.
Q:What is the growth outlook for the company's three business segments?
A:Home Health & Hospice and Medical Solutions are expected to achieve high single-digit to double-digit growth. PDS is expected to grow at a normalized rate of 5%-7%.
Q:What is the company's strategy for entering new states in the PDS segment?
A:The company evaluates new states based on Medicaid population, PDN patient numbers, and pediatric population. It aims to work with government and payer partners to address wage and reimbursement rates.
Q:Review of Unclear Management Responses
A:Management avoided giving a direct answer regarding the realistic scenario for California's home-based nursing rates in 2026-2027, stating that there is no PDN rate increase in the budget and that the likelihood of inclusion in the May revised budget is low. They also provided limited detail on the specific financial impact of weather-related disruptions and respiratory seasonality on the 2026 outlook.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Duty Services
Family Homecare
Family acquisition
Family teammate
Family transaction
Florida reputation
Health Hospice
Holdings Today
Home Health
Homecare Florida
Homecare acquisition
Homecare company
Hospice Medical
Medical Solutions
PDS stake
Pediatrics Family
Private Duty
Services MCO
Services government
Services pay
Services rate
Solutions digit
accounting calendar
acquisition closing
acquisition highlight
acquisition leverage
acquisition mind
acquisition story
adjustment payer
agreement Private
agreement home
agreement payer
end payer
pay agreement
payer mix
strategy
AVAH Transcript
Aveanna Healthcare Holdings Inc. (AVAH) Q1 2026 Earnings Call Transcript
Unknown5-14
The earnings call presents a mixed picture: revenue and adjusted EBITDA grew modestly, but net income fell due to increased expenses. Operational updates and strategic initiatives were not discussed, limiting insight into future growth. Risk factors were highlighted, but no new partnerships or guidance changes were announced. With no major catalysts or negative surprises, the stock price is likely to remain stable, leading to a neutral sentiment.
Aveanna Healthcare Holdings Inc. (AVAH) Q4 2025 Earnings Call Transcript
Positive3-19
The earnings call indicates strong cash collections and cost efficiency, contributing to a positive free cash flow. The Family First acquisition is expected to be accretive and minimally impact leverage. Positive growth outlooks across business segments and AI initiatives further enhance sentiment. While some uncertainties exist, such as California's home-based nursing rates, the overall sentiment is positive due to strong financial performance and strategic growth plans.
Aveanna Healthcare Holdings Inc. (AVAH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Neutral1-14
Aveanna Healthcare Holdings Inc. (AVAH) Presents at Bank of America Home Care Conference Transcript
Neutral12-9
AVAH Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
